These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of omeprazole on rat gastric mucus glycoproteins with acetylsalicylic acid-induced gastric damage.
    Author: Ohara S, Murayama N, Kuwata H, Ishihara K, Hotta K.
    Journal: Arch Int Pharmacodyn Ther; 1988; 296():192-201. PubMed ID: 3240017.
    Abstract:
    Investigations were carried out to determine the effects of omeprazole on mucus glycoprotein in rat gastric mucosa. Quantitative and qualitative changes in mucus glycoprotein, isolated from omeprazole-treated rats with or without acetylsalicylic acid-induced gastric damage, and the degree of gastric mucosal injury were studied. Omeprazole, in a dose-dependent manner, prevented macroscopical mucosal damage induced by acidified acetylsalicylic acid. A considerable decrease in corpus mucus glycoprotein (54%) and antral mucus glycoprotein (72%) was observed in acetylsalicylic acid-treated rats and acetylsalicylic acid reduced the amounts of fucose and galactose of corpus mucus glycoprotein. Pretreatment with omeprazole partially restored a quantitative reduction and a qualitative change of carbohydrate portion in corpus mucus glycoprotein induced by acetylsalicylic acid. A single administration of a high dose of omeprazole (200 mumol/kg) also induced the reduction of corpus mucus glycoprotein content (82%), although no changes in the carbohydrate component were observed. The decrease in corpus mucus glycoproteins induced by omeprazole might be due to a cause different from that of acetylsalicylic acid-induced mucus glycoprotein reduction.
    [Abstract] [Full Text] [Related] [New Search]